BRK-B vs GABC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GABC presents a strong value opportunity, trading below its Graham Number ($46.20) and significantly below its growth-based intrinsic value ($90.27). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company exhibits explosive YoY revenue growth (45.30%) and robust earnings growth (21.70%). Despite a heavily bearish technical trend (10/100), the fundamental valuation and consistent earnings beat track record suggest a significant margin of safety.
Compare Another Pair
Related Comparisons
BRK-B vs GABC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and German American Bancorp, Inc. (GABC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.